Products List Page - Pharmacodia

Home > Drug Search >

Bio-Type： Recombinant enzyme

Drug Filter

Status：

Approved (36) BLA Filing (1) Phase Ⅲ (12) Phase Ⅱ (12) Phase Ⅰ (4)

More Retract Multiple

OK Cancel

Clinical Stage：

Pending (3) Active (23) Discontinued (3)

More Retract Multiple

OK Cancel

Company：

Cornerstone Therapeutics (1) Sumitomo Dainippon (1) Dong-A Pharmaceutical (1) Eisai (1) Genentech (3) Genzyme (7) GlaxoSmithKline (1) Kyowa Hakko Kirin (2) MedImmune (1) Mitsubishi Tanabe Pharma (1) National Institutes of Health (1) Pfizer (1) Roche (1) Sanofi (1) Shire (5) SOBI (1) Teijin Pharma (1) University of California (1) Apeiron Biologics (2) 3SBio (1) EnzymeRx (1) Selecta Biosciences (1) Reliance Life Sciences (1) Kamada (1) Halozyme Therapeutics (1) Biocon (1) Indiana University (1) International Biotech Center Generium (2) JCR Pharmaceuticals (1) University of Texas M. D. Anderson Cancer Center (1) Sedico (2) Virchow Group (1) Bio-Cancer Treatment International (1) Mayoly-Spindler (1) AzurRx (1) America Stem Cell (1) Oregon Health & Science University (1) Targazyme (1) Wake Forest University School of Medicine (1) Alloksys Life Sciences (1) CEVEC Pharmaceuticals (1) AMRIF (1) Shanghai Fudan-Zhangjiang Bio-Pharmaceutical (1) LTT Bio-Pharma (1) AM-Pharma (1) Polymun Scientific (1) Harvest Moon (1) Shandong Ahua Biochemical (1) Mochida (1) 上海凯茂生物医药 (1) Crealta Pharmaceutical (1) rEVO Biologics (1) ThromboGenics (1) Protalix Biotherapeutics (1) Shanghai Tasly Pharmaceutical (1) Chengdu Diao Jiuhong Pharmaceutical (1) Tonghua Yujin Pharmaceutical (1) Qingdao Guoda Biological Pharmaceuticals (1) Sigma-Tau (1) Ultragenyx (1) Proteon Therapeutics (1) National Institute of Mental Health (1) Zymenex (1) Polaris (2) QSV Pharma (1) Enzon Pharmaceuticals (1) Medac GmbH (1) Actavis (1) Alcon (1) Alexion (2) Astellas (1) AstraZeneca (1) Bayer (2) BioMarin Pharmaceutical (6) Boehringer Ingelheim (2) Bristol-Myers Squibb (1) BTG plc (1) Chiesi (1) Chugai (1)

More Retract Multiple

OK Cancel

Indication：

Acute coronary syndrome (ACS) (1) Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (1) Chronic gout (1) Coronary artery disease (CAD) (1) Metachromatic leukodystrophy (1) Cystic fibrosis (CF) (1) Neuronal ceroid lipofuscinoses (1) Deep vein thrombosis (DVT) (2) Gaucher's disease (GD) (7) Pancreatitis (1) Hepatocellular carcinoma (HCC) (2) Tumour lysis syndrome (1) Hyperuricemia (2) Metastatic melanoma (1) Myocardial infarction (MI) (8) Vascular disorders (1) Niemann-Pick diseases (1) Peripheral arterial disease (PAD) (1) Pneumonia (1) Pulmonary embolism (3) Mucopolysaccharidosis III (2) Peyronie's disease (1) Cellulite (1) Rheumatoid arthritis (RA) (1) Ulcerative colitis (1) Fabry disease (3) Radiodermatitis (1) Acute Lung Injury (1) Hypophosphatasia (1) Acute ischemic stroke (AIS) (1) Acute myocardial infarction (AMI) (7) Acute massive pulmonary embolism (2) Mucopolysaccharidosis type IVA (Morquio A syndrome) (1) Mucopolysaccharidosis VI (Maroteaux-Lamy syndrome) (1) Toxic plasma methotrexate concentrations (1) Glycogen storage disease type II (2) Mucopolysaccharidosis II (Hunter syndrome) (1) Mucopolysaccharidosis I (1) Plasma uric acid management (1) Hereditary antithrombin deficiency (2) Disseminated intravascular coagulation (DIC) (1) Symptomatic vitreomacular adhesion (1) Lysosomal acid lipase deficiency (1) Adenosine deaminase deficiency (1) Mucopolysaccharidosis VII (Sly syndrome) (1) Fat malabsorption (1) Retinal vein occlusion (1) Phenylketonuria (PKU) (1) Graft versus host disease (1) Bleeding (1) Gout (1) Acute kidney injury (1) Thromboembolism (1) hematological malignancies (1) Respiratory distress syndrome (1) Alpha-1 antitrypsin deficiency (1)

More Retract Multiple

OK Cancel

Country：

US (11) EU (6) CN (2)

More Retract Multiple

OK Cancel

Aprv. Year：